Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells

An efficient vaccine against human immunodeficiency virus (HIV) must induce good cellular immune responses. To do this, it must be processed and presented by dendritic cells, which are required for primary T-lymphocyte stimulation. We have previously shown that a model lipopeptide containing a short...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Andrieu, Muriel, Desoutter, Jean-François, Loing, Estelle, Gaston, Jésintha, Hanau, Daniel, Guillet, Jean-Gérard, Hosmalin, Anne
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Virus-Cell Interactions
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140847/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12502869/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.2.1564-1570.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!